Danaher Schedules Third Quarter 2022 Earnings Conference Call

WASHINGTON, Sept. 20, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2022 on Thursday, October 20, 2022 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of... Read more

Danaher Announces Intention to Separate Environmental & Applied Solutions Segment to Create an Independent, Publicly Traded Company

Danaher Announces Intention to Separate Environmental & Applied Solutions Segment to Create an Independent, Publicly Traded Company WASHINGTON, Sept. 14, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) today announced its intention to separate its Environmental & Applied Solutions segment to create an independent, publicly traded company. The new company will be comprised of Danaher’s Water... Read more

Improving the Working Environment and Reducing Environmental impacts by Digital transformation of the Production Lines—Shimane Shimadzu Corporation, The Medical System Manufacturing Subsidiary of Shimadzu Co.—

Improving the Working Environment and Reducing Environmental impacts by Digital transformation of the Production Lines—Shimane Shimadzu Corporation, The Medical System Manufacturing Subsidiary of Shimadzu Co.— Read more

PerkinElmer Accelerates Transformation into High Growth, High Margin Life Sciences & Diagnostics Company

Enters agreement with intention to divest Applied, Food and Enterprise Services businesses WALTHAM, Mass.–(BUSINESS WIRE)–Aug. 1, 2022– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced it has entered into an agreement with the intention to divest its Applied, Food and Enterprise Services businesses to New Mountain Capital,... Read more

Two PerkinElmer Tests Added to UK’s Updated NICE Diagnostic Guidance for Suspected Preterm Pre-Eclampsia

WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that a placental growth factor (PlGF) measurement using its DELFIA® Xpress PlGF 1-2-3TM kit (CE-IVD) and a soluble fms-like tyrosine kinase 1 (sFlt-1)/PlGF ratio using its DELFIA® Xpress sFlt-1 kit (CE-IVD), have been included in an updated diagnostic guidance issued by the United Kingdom’s National... Read more

PerkinElmer Elects Dr. Michelle McMurry-Heath to its Board of Directors

WALTHAM, Mass.–(BUSINESS WIRE)–Jul. 22, 2022– PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that Dr. Michelle McMurry-Heath has been elected to its board of directors, effective July 22, 2022. “I am pleased to welcome Michelle to PerkinElmer’s board and excited to see the Company benefit from both her... Read more